April 15, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Five Drugmakers, Including Recursion & Servier, Team Up On Privacy-Preserving ADMET Network
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Pharma & Biopharma > Five Drugmakers, Including Recursion & Servier, Team Up On Privacy-Preserving ADMET Network
Pharma & Biopharma

Five Drugmakers, Including Recursion & Servier, Team Up On Privacy-Preserving ADMET Network

By Newsroom
Last updated: March 1, 2026
1 Min Read
Share


  News

Five pharmaceutical companies, including Lundbeck, Orion Pharma, Recursion, Servier, and one undisclosed organization, have committed around 80% of their internal ADMET datasets to a privacy-preserving federated learning network coordinated by Berlin-based Apheris, according to reporting by GEN Edge. The initiative aims to improve model performance in predicting absorption, distribution, metabolism, excretion, and toxicity, while allowing participants to retain control over proprietary data.

…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

First Quarterly Stormwater Sampling Deadline of 2025 Approaching

Environmental Science
April 5, 2025

How to make scalability your strategic advantage

Download this free whitepaper to learn more. Scaling a promising biologic from bench to market…

April 15, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Insilico Medicine Files for Hong Kong IPO, Aims to Raise $292M

AI drug developer Insilico Medicine has returned to the Hong Kong public markets with an updated IPO prospectus, targeting about $292…

Pharma & Biopharma
December 21, 2025

Alnylam’s patisiran, the first ever FDA- and European Commission-approved RNAi therapeutic

Lipid nanoparticle structure On August 10, 2018, Alnylam Pharmaceuticals (Cambridge, MA) announced the first-ever FDA approval of an RNAi (RNA…

Pharma & Biopharma
May 3, 2025

Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3

The layoffs affect Swiss manufacturing facilities. Elsewhere, the FDA pushed back an approval deadline and a mid-stage study showed Novo’s…

Pharma & Biopharma
November 30, 2025

Antheia and TAPI Announce Strategic Partnership to Scale Biosynthetic Pharmaceutical Manufacturing

  News Antheia and TAPI have formed a strategic partnership to accelerate global commercialization of Antheia’s biosynthetic manufacturing platform for key…

Pharma & Biopharma
December 7, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

How to make scalability your strategic advantage
April 15, 2026
Redefining Type 1 Diabetes Treatment with Cell and Gene…
April 15, 2026
Isolating Extracellular Vesicles Using a High-Speed and…
April 15, 2026
Mouse TNF Kit Market Growth Drivers and Opportunities
April 15, 2026

Life Science Magazines

How to make scalability your strategic advantage
April 15, 2026
Redefining Type 1 Diabetes Treatment with Cell and Gene…
April 15, 2026
Isolating Extracellular Vesicles Using a High-Speed and…
April 15, 2026
Powering Drug Development with Advanced Retrosynthetic…
April 15, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?